- Home
- DNN vs TARS Comparison
DNN vs TARS Comparison
Compare DNN & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- TARS
- Stock Information
- Founded
- DNN 1954
- TARS 2016
- Country
- DNN Canada
- TARS United States
- Employees
- DNN N/A
- TARS N/A
- Industry
- DNN Other Metals and Minerals
- TARS Medicinal Chemicals and Botanical Products
- Sector
- DNN Basic Materials
- TARS Health Care
- Exchange
- DNN Nasdaq
- TARS Nasdaq
- Market Cap
- DNN 1.8B
- TARS 1.7B
- IPO Year
- DNN 1997
- TARS 2020
- Fundamental
- Price
- DNN $2.08
- TARS $57.25
- Analyst Decision
- DNN Strong Buy
- TARS Strong Buy
- Analyst Count
- DNN 2
- TARS 7
- Target Price
- DNN $3.00
- TARS $67.14
- AVG Volume (30 Days)
- DNN 58.4M
- TARS 737.4K
- Earning Date
- DNN 08-07-2025
- TARS 08-06-2025
- Dividend Yield
- DNN N/A
- TARS N/A
- EPS Growth
- DNN N/A
- TARS N/A
- EPS
- DNN N/A
- TARS N/A
- Revenue
- DNN $3,311,190.00
- TARS $295,521,000.00
- Revenue This Year
- DNN $231.59
- TARS $122.94
- Revenue Next Year
- DNN $44.50
- TARS $44.14
- P/E Ratio
- DNN N/A
- TARS N/A
- Revenue Growth
- DNN 12.14
- TARS 254.45
- 52 Week Low
- DNN $1.08
- TARS $25.14
- 52 Week High
- DNN $2.47
- TARS $57.57
- Technical
- Relative Strength Index (RSI)
- DNN 52.81
- TARS 79.79
- Support Level
- DNN $1.86
- TARS $53.15
- Resistance Level
- DNN $2.11
- TARS $55.17
- Average True Range (ATR)
- DNN 0.11
- TARS 2.03
- MACD
- DNN -0.03
- TARS 0.89
- Stochastic Oscillator
- DNN 43.00
- TARS 97.95
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.